ANDA 76296, held by Fresenius Kabi USA. Vincristine Sulfate.
As of Nov 15, 2026, ANDA 76296 (Vincristine Sulfate), held by Fresenius Kabi USA, was first approved by FDA on Dec 20, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vincristine Sulfate1MG/ML ยท injectable;injection | Vincristine Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
